학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 19건 | 목록
1~20
Academic Journal
Bergantim R; i3S - Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal.; IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal.; Clinical Hematology, Hospital Center of São João, Porto, Portugal.; Clinical Hematology, FMUP - Faculty of Medicine of the University of Porto, Porto, Portugal.; Peixoto da Silva S; i3S - Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal.; IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal.; Department of Biological Sciences, FFUP - Faculty of Pharmacy of the University of Porto, Porto, Portugal.; Pinto V; i3S - Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal.; IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal.; Pereira JM; i3S - Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal.; IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal.; Sousa D; Faculty of Dental Medicine (FMD), Universidade Católica Portuguesa, Viseu, Portugal.; Unit for Multidisciplinary Research in Biomedicine (UMIB), School of Medicine and Biomedical Sciences (ICBAS), University of Porto, Porto, Portugal.; Laboratory of Integrative and Translocation Research in Population Health (ITR), Porto, Portugal.; Trigo F; Clinical Hematology, Hospital Center of São João, Porto, Portugal.; Matthiesen R; Computational and Experimental Biology Group, iNOVA4Health, NOVA Medical School, Faculdade de Ciências Médicas, NMS|FCM, Universidade Nova de Lisboa, Lisboa, Portugal.; Guimarães JE; i3S - Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal.; IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal.; Clinical Hematology, Hospital Center of São João, Porto, Portugal.; Clinical Hematology, FMUP - Faculty of Medicine of the University of Porto, Porto, Portugal.; Instituto Universitário de Ciências da Saúde, Cooperativa de Ensino Superior Politécnico e Universitário IUCSESPU, Paredes, Portugal.; Vasconcelos MH; i3S - Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal.; IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal.; Department of Biological Sciences, FFUP - Faculty of Pharmacy of the University of Porto, Porto, Portugal.
Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Academic Journal
Academic Journal
Baron F; GIGA-I3 and CHU, University of Liège, Liège, Belgium.; Efficace F; Gruppo Italiano Malattie Ematologiche Dell'Adulto GIMEMA, Rome, Italy.; Cannella L; Gruppo Italiano Malattie Ematologiche Dell'Adulto GIMEMA, Rome, Italy.; Muus P; Radboud University Medical Center, Nijmegen, Netherlands.; Trisolini S; Sapienza University, Rome, Italy.; Halkes CJM; Leiden University Medical Center, Leiden, Netherlands.; Fazi P; Gruppo Italiano Malattie Ematologiche Dell'Adulto GIMEMA, Rome, Italy.; Vignetti M; Gruppo Italiano Malattie Ematologiche Dell'Adulto GIMEMA, Rome, Italy.; Marie JP; Saint-Antoine Hospital, Paris, France.; Chiusolo P; Gemelli Hospital, Rome, Italy.; van der Velden W; Radboud University Medical Center, Nijmegen, Netherlands.; La Sala E; Gruppo Italiano Malattie Ematologiche Dell'Adulto GIMEMA, Rome, Italy.; Vitolo U; Candiolo Cancer Institute-IRCCS, Torino, Italy.; Thomas X; Lyon-Sud University Hospital, Lyon, France.; Lefrère F; Assistance Publique-Hôpitaux de Paris, Necker Children's Hospital, Paris, France.; Di Raimondo F; Universita di Catania, Catania, Italy.; Bourhis JH; Gustave Roussy cancer campus Grand Paris, Villejuif, France.; Specchia G; Giovanni XXIII- University Hospital, Bari, Italy.; Guimarães JE; Hospital S. João, Porto, Portugal.; Allione B; Candiolo Cancer Institute-IRCCS, Torino, Italy.; Vrhovac R; University Hospital Centre Zagreb, Zagreb, Croatia.; Ferrara F; Cardarelli Hospital, Naples, Italy.; Stevens-Kroef M; Radboud University Medical Center, Nijmegen, Netherlands.; Meert L; EORTC Headquarters, Brussels, Belgium.; de Witte T; Radboud University Medical Center, Nijmegen, Netherlands.; Willemze R; Leiden University Medical Center, Leiden, Netherlands.; Amadori S; University Tor Vergata, Rome, Italy.; Suciu S; EORTC Headquarters, Brussels, Belgium.
Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE
Academic Journal
Cancer Gene Therapy. May 01, 2004 11(5):309-316
Negative MR4·0 chronic myeloid leukaemia and its possible implications for treatment-free remission.
Editorial & Opinion
Cerveira N; Serviço de Genética, Instituto Português de Oncologia do Porto, Porto, Portugal.; Diamond J; Laboratório de Hemato-Oncologia, Instituto Português de Oncologia de Lisboa, Lisboa, Portugal.; Matos S; GenoMed - Diagnósticos de Medicina Molecular, Lisboa, Portugal.; Amorim ML; Departmento de Hematologia Clínica, Centro Hospitalar Universitário de São João, Porto, Portugal.; Coucelo M; Departmento de Hematologia Clínica, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.; Bizarro S; Serviço de Genética, Instituto Português de Oncologia do Porto, Porto, Portugal.; Simões AT; Departmento de Hematologia Clínica, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.; Pierdomenico F; Departmento de Hematologia, Instituto Português de Oncologia de Lisboa, Lisboa, Portugal.; Lopes M; Departmento de Hematologia Clínica, Centro Hospitalar Universitário de São João, Porto, Portugal.; Ribeiro L; Departmento de Hematologia Clínica, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.; do Carmo-Fonseca M; GenoMed - Diagnósticos de Medicina Molecular, Lisboa, Portugal.; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.; Guimarães JE; Departmento de Hematologia Clínica, Centro Hospitalar Universitário de São João, Porto, Portugal.; Faculdade de Medicina, Universidade do Porto, Porto, Portugal.; Almeida A; Laboratório de Hemato-Oncologia, Instituto Português de Oncologia de Lisboa, Lisboa, Portugal.; Departmento de Hematologia, Hospital da Luz, Lisboa, Portugal.; Teixeira MR; Serviço de Genética, Instituto Português de Oncologia do Porto, Porto, Portugal.; Instituto de Ciências Biomédicas, Universidade do Porto, Porto, Portugal.
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Academic Journal
Bergantim R; i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.; Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135 Porto, Portugal.; Clinical Hematology, Hospital Center of São João, 4200-319 Porto, Portugal.; Clinical Hematology, FMUP-Faculty of Medicine of the University of Porto, 4200-319 Porto, Portugal.; Peixoto da Silva S; i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.; Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135 Porto, Portugal.; Polónia B; i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.; Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135 Porto, Portugal.; Barbosa MAG; i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.; Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135 Porto, Portugal.; Albergaria A; i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.; Research Innovation Unit, Translational Research & Industry Partnerships Office, i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.; Lima J; i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.; Research Innovation Unit, Translational Research & Industry Partnerships Office, i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.; Caires HR; i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.; Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135 Porto, Portugal.; Guimarães JE; i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.; Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135 Porto, Portugal.; Clinical Hematology, Hospital Center of São João, 4200-319 Porto, Portugal.; Clinical Hematology, FMUP-Faculty of Medicine of the University of Porto, 4200-319 Porto, Portugal.; Instituto Universitário de Ciências da Saúde, Cooperativa de Ensino Superior Politécnico e Universitário IUCSESPU, 4585-116 Gandra-Paredes, Portugal.; Vasconcelos MH; i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.; Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135 Porto, Portugal.; Department of Biological Sciences, FFUP-Faculty of Pharmacy of the University of Porto, 4050-313 Porto, Portugal.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
Academic Journal
Peixoto da Silva S; i3S - Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal; Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135, Porto, Portugal.; Caires HR; i3S - Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal; Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135, Porto, Portugal.; Bergantim R; i3S - Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal; Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135, Porto, Portugal; Clinical Hematology, Hospital São João, 4200-319, Porto, Portugal; Clinical Hematology, FMUP - Faculty of Medicine, University of Porto, 4200-319, Porto, Portugal.; Guimarães JE; i3S - Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal; Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135, Porto, Portugal; Clinical Hematology, FMUP - Faculty of Medicine, University of Porto, 4200-319, Porto, Portugal; Instituto Universitário de Ciências da Saúde, Cooperativa de Ensino Superior Politécnico e Universitário, IUCSCESPU, 4585-116, Gandra, Paredes, Portugal.; Vasconcelos MH; i3S - Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal; Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135, Porto, Portugal; Department of Biological Sciences, FFUP - Faculty of Pharmacy, University of Porto, 4050-313, Porto, Portugal. Electronic address: hvasconcelos@ipatimup.pt.
Publisher: Academic Press Country of Publication: England NLM ID: 9010218 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-3650 (Electronic) Linking ISSN: 1044579X NLM ISO Abbreviation: Semin Cancer Biol Subsets: MEDLINE
Academic Journal
Xavier CPR; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.; Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology, University of Porto, 4200-135 Porto, Portugal.; Caires HR; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.; Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology, University of Porto, 4200-135 Porto, Portugal.; Barbosa MAG; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.; Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology, University of Porto, 4200-135 Porto, Portugal.; Bergantim R; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.; Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology, University of Porto, 4200-135 Porto, Portugal.; Clinical Hematology, Hospital São João, 4200-319 Porto, Portugal.; Clinical Hematology, FMUP-Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.; Guimarães JE; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.; Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology, University of Porto, 4200-135 Porto, Portugal.; Clinical Hematology, FMUP-Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.; Cooperativa de Ensino Superior Politécnico e Universitário, CESPU, 4585-116 Gandra, Paredes, Portugal.; Vasconcelos MH; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.; Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology, University of Porto, 4200-135 Porto, Portugal.; Department of Biological Sciences, FFUP-Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE
Academic Journal
Amadori, Sergio; Suciu, Stefan; Stasi, Roberto; Salih, Helmut R; Selleslag, Dominik; Muus, Petra; De Fabritiis, Paolo; Venditti, Adriano; Ho, Anthony D; Lübbert, Michael; Thomas, Xavier; Latagliata, Roberto; Halkes, Constantijn J M; Falzetti, Franca; Magro, Domenico; Guimaraes, José E; Berneman, Zwi; Specchia, Giorgina; Karrasch, Matthias; Fazi, Paola; et al
Academic Journal
Bastos BL; Loureiro D; Raynal JT; Guedes MT; Vale VL; Moura-Costa LF; Guimarães JE; Azevedo V; Portela RW; Meyer R; Laboratório de Imunologia e Biologia Molecular, Departamento de Biointeração, Instituto de Ciências da Saúde, Universidade Federal da Bahia, Av, Reitor Miguel Calmon, S/N - Vale do Canela, Salvador, BA CEP 40140-100, Brazil. meyer.roberto@gmail.com.
Publisher: BioMed Central Country of Publication: England NLM ID: 101249759 Publication Model: Electronic Cited Medium: Internet ISSN: 1746-6148 (Electronic) Linking ISSN: 17466148 NLM ISO Abbreviation: BMC Vet Res Subsets: MEDLINE
Academic Journal
Pinto V; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.; Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135 Porto, Portugal.; FCTUC-Faculty of Science and Technology of the University of Coimbra, 3030-790 Coimbra, Portugal.; Bergantim R; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.; Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135 Porto, Portugal.; Clinical Hematology, Hospital São João, 4200-319 Porto, Portugal.; Clinical Hematology, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.; Caires HR; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.; Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135 Porto, Portugal.; Seca H; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.; Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135 Porto, Portugal.; Guimarães JE; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.; Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135 Porto, Portugal.; Clinical Hematology, Hospital São João, 4200-319 Porto, Portugal.; Clinical Hematology, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.; Vasconcelos MH; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.; Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135 Porto, Portugal.; Department of Biological Sciences, FFUP-Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Academic Journal
Nagler A; Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel.; Labopin M; Acute Leukemia Working Party -EBMT, Hôpital Saint Antoine, AP-HP, Université Pierre et Marie Curie Paris 6 UPMC, INSERM UMR-S 938, Paris, France.; Gorin NC; Acute Leukemia Working Party -EBMT, Hôpital Saint Antoine, AP-HP, Université Pierre et Marie Curie Paris 6 UPMC, INSERM UMR-S 938, Paris, France Department of Hematology and Cell Therapy, Hospital Saint Antoine, Paris, France norbert-claude.gorin@sat.aphp.fr.; Ferrara F; Cardarelli Hospital, Napoli, Italy.; Sanz MA; Hospital Universitario La Fe, University of Valencia, Spain.; Wu D; First Affiliated Hospital of Soochow University, Suzhou, China.; Gomez AT; Hospital Reina Sofia, Córdoba, Spain.; Lapusan S; Department of Hematology and Cell Therapy, Hospital Saint Antoine, Paris, France.; Irrera G; Azienda Ospedaliera, Reggio Calabria, Italy.; Guimaraes JE; Hospital Sao Joao and School of Medicine, Porto, Portugal.; Sousa AB; Hospital dos Capuchos, Lisboa, Portugal.; Carella AM; Hospital San Martino, Genova, Italy.; Vey N; Centre Paoli Calmettes, Marseille, France.; Arcese W; Rome Transplant Network, Rome, Italy.; Shimoni A; Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel.; Berger R; Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel.; Rocha V; Churchill Hospital, Oxford University, UK.; Mohty M; Acute Leukemia Working Party -EBMT, Hôpital Saint Antoine, AP-HP, Université Pierre et Marie Curie Paris 6 UPMC, INSERM UMR-S 938, Paris, France Department of Hematology and Cell Therapy, Hospital Saint Antoine, Paris, France.
Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE
Academic Journal
Willemze R; Roelof Willemze, Constantijn J.M. Halkes, and Erik W.A. Marijt, Leiden University Medical Center, Leiden; Petra Muus, Joop Jansen, and Theo de Witte, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands; Stefan Suciu and Liv Meert, European Organisation for Research and Treatment of Cancer Headquarters; Dominique Bron, Hôpital Universitaire, Bordet-Erasme, Brussels; Dominik L.D. Selleslag, Algemeen Ziekenhuis Sint-Jan, Brugge; Zwi Berneman, Universitair Ziekenhuis, Antwerpen; Georges Fillet, Centre Hospitalier Universitaire du Sart-Tilman, Liège; Anne Hagemeijer, Center for Human Genetics, University of Leuven, Leuven, Belgium; Giovanna Meloni, Marco Mancini, Silvia Maria Trisolini, and Franco Mandelli, 'Sapienza' University; Sergio Amadori and Adriano Venditti, Tor Vergata University Hospital; Simona Sica, Università Cattolica del Sacro Cuore, Policlinico A. Gemelli; Paola Fazi and Marco Vignetti, Gruppo Italiano Malattie Ematologiche dell' Adulto Foundation, Central Office, Rome; Giorgina Specchia, Università degli Studi di Bari, Bari; Francesco Fabbiano, Ospedali Riuniti 'Villa Sofia-Cervello'; Maria Enza Mitra, Policlinico 'Paolo Giaccone,' Palermo; Francesco Nobile, Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria; Marco Sborgia, Azienda Unitá Sanitaria Locale di Pescara, Pescara; Andrea Camera, L'A.O. Universitaria-Università degli Studi di Napoli 'Federico II,' Napoli; Domenico Magro, A.O. Pugliese Ciaccio, Catanzaro; Nicola Cantore, A.O. San Giuseppe Moscati, Avellino; Lorella Melillo, Istituto Di Ricovero e Cura a Carattere Scientifico Casa Sollievo della Sofferenza, San Giovanni Rotondo; Pietro Leoni, A.O. Nuovo Ospedale Torrette, Ancona; Mario Luppi, A.O. Universitaria di Modena, Modena; Daniela Cilloni, University of Torino, Torino, Italy; Boris Labar, University Hospital Center-Rebro, Zagreb, Croatia; Jean-Pierre Marie, Saint-Antoine Hospital, Assistance Publique-Hopitaux de Paris and University Paris 6; Francois Lef; Suciu S; Meloni G; Labar B; Marie JP; Halkes CJ; Muus P; Mistrik M; Amadori S; Specchia G; Fabbiano F; Nobile F; Sborgia M; Camera A; Selleslag DL; Lefrère F Sr; Magro D; Sica S; Cantore N; Beksac M; Berneman Z; Thomas X; Melillo L; Guimaraes JE; Leoni P; Luppi M; Mitra ME; Bron D; Fillet G; Marijt EW; Venditti A; Hagemeijer A; Mancini M; Jansen J; Cilloni D; Meert L; Fazi P; Vignetti M; Trisolini SM; Mandelli F; de Witte T
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Seca H; Lima RT; Almeida GM; Sobrinho-Simoes M; Bergantim R; Guimaraes JE; Vasconcelos MH; Cancer Drug Resistance Group, IPATIMUP, Rua Dr Roberto Frias, s/n 4200-465 Porto, Portugal. hvasconcelos@ipatimup.pt.
Publisher: Bentham Science Publishers Country of Publication: Netherlands NLM ID: 100960530 Publication Model: Print Cited Medium: Internet ISSN: 1873-4316 (Electronic) Linking ISSN: 13892010 NLM ISO Abbreviation: Curr Pharm Biotechnol Subsets: MEDLINE
Academic Journal
Seca H; Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal.; Lima RT; Lopes-Rodrigues V; Guimaraes JE; Almeida GM; Vasconcelos MH
Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 100960531 Publication Model: Print Cited Medium: Internet ISSN: 1873-5592 (Electronic) Linking ISSN: 13894501 NLM ISO Abbreviation: Curr Drug Targets Subsets: MEDLINE
Academic Journal
Bergantim R; Service of Clinical Hematology, Hospital São João, Porto, Portugal. rui.bergantim@gmail.com.; Trigo F; Guimarães JE
Publisher: BioMed Central Country of Publication: England NLM ID: 101590676 Publication Model: Electronic Cited Medium: Print ISSN: 2162-3619 (Print) Linking ISSN: 21623619 NLM ISO Abbreviation: Exp Hematol Oncol Subsets: PubMed not MEDLINE
Academic Journal
Bastos BL; Immunology and Molecular Biology Laboratory, Health Sciences Institute.; Veterinary Clinical Pathology Laboratory.; Meyer R; Immunology and Molecular Biology Laboratory, Health Sciences Institute.; Guimarães JE; Veterinary Clinical Pathology Laboratory.; Ayres MC; Veterinary Clinical Pathology Laboratory.; Guedes MT; Immunology and Molecular Biology Laboratory, Health Sciences Institute.; Moura-Costa LF; Immunology and Molecular Biology Laboratory, Health Sciences Institute.; de Burghgrave US; Veterinary Clinical Pathology Laboratory.; Sena L; Immunology and Molecular Biology Laboratory, Health Sciences Institute.; Azevedo V; Molecular and Cellular Genetics Laboratory, Biological Sciences Institute, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.; Portela RW; Immunology and Molecular Biology Laboratory, Health Sciences Institute.
Publisher: American Society for Veterinary Clinical Pathology Country of Publication: United States NLM ID: 9880575 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1939-165X (Electronic) Linking ISSN: 02756382 NLM ISO Abbreviation: Vet Clin Pathol Subsets: MEDLINE
Academic Journal
Seca H; IPATIMUP, Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal.; Almeida GM; Guimarães JE; Vasconcelos MH
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Academic Journal
Vasconcelos MH; Institute of Molecular Pathology and Immunology, University of Porto, Portugal.; Maia LF; Sousa C; Beleza SS; Guimarães JE
Publisher: Japanese Pharmacological Society Country of Publication: Japan NLM ID: 101167001 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1347-8613 (Print) Linking ISSN: 13478613 NLM ISO Abbreviation: J Pharmacol Sci Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Guimarães, José E
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어